Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

作者: Gregory J. Riely , Mark G. Kris , Daniel Rosenbaum , Jenifer Marks , Allan Li

DOI: 10.1158/1078-0432.CCR-08-0646

关键词: AdenocarcinomaCancerLung cancerMutationMedicineOncologyErlotinibInternal medicineKRASGefitinibPathologyConfidence interval

摘要: … which tumors have KRAS mutations by any clinical characteristics. Based on these data, we … interest in the molecular basis of lung cancer in patients who never smoked cigarettes (1–3). …

参考文章(24)
Stephen L. Graziano, Gary P. Gamble, Nancy B. Newman, Lynn Z. Abbott, Michelle Rooney, Sulagna Mookherjee, Melissa L. Lamb, Leslie J. Kohman, Bernard J. Poiesz, Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 17, pp. 668- 668 ,(1999) , 10.1200/JCO.1999.17.2.668
Steven A. Ahrendt, P. Anthony Decker, Enas A. Alawi, Yong-ran Zhu, Montserrat Sanchez-Cespedes, Stephen C. Yang, George B. Haasler, André Kajdacsy-Balla, Michael J. Demeure, David Sidransky, Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. ,vol. 92, pp. 1525- 1530 ,(2001) , 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H
Shanrong Li, Zdenek Skacel, José Gómez-Codina, Carlos Camps, Mariano Monzó, Josep M. de Anta, Rafael Rosell, Francisco Molina, Isabel Moreno, Eva Martínez, Alex Pifarré, Albert Font, Mutated K-ras gene analysis in a randomized trial of preoperative chemotherapy plus surgery versus surgery in stage IIIA non-small cell lung cancer. Lung Cancer. ,vol. 12, ,(1995) , 10.1016/0169-5002(95)00421-V
Fiamma Buttitta, Fabio Barassi, Giuseppina Fresu, Lara Felicioni, Antonio Chella, Diego Paolizzi, Giuseppe Lattanzio, Simona Salvatore, Pier P. Camplese, Sandra Rosini, Teodorico Iarussi, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Antonio Marchetti, Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features. International Journal of Cancer. ,vol. 119, pp. 2586- 2591 ,(2006) , 10.1002/IJC.22143
D. M. Parkin, P. Pisani, A. D. Lopez, E. Masuyer, At least one in seven cases of cancer is caused by smoking. Global estimates for 1985 International Journal of Cancer. ,vol. 59, pp. 494- 504 ,(1994) , 10.1002/IJC.2910590411
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 74- 108 ,(2005) , 10.3322/CANJCLIN.55.2.74
Sophie Sun, Joan H. Schiller, Adi F. Gazdar, Lung cancer in never smokers — a different disease Nature Reviews Cancer. ,vol. 7, pp. 778- 790 ,(2007) , 10.1038/NRC2190
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Janakiraman Subramanian, Ramaswamy Govindan, Lung Cancer in Never Smokers: A Review Journal of Clinical Oncology. ,vol. 25, pp. 561- 570 ,(2007) , 10.1200/JCO.2006.06.8015
H. H. Nelson, D. C. Christiani, E. J. Mark, J. K. Wiencke, J. C. Wain, K. T. Kelsey, Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. Journal of the National Cancer Institute. ,vol. 91, pp. 2032- 2038 ,(1999) , 10.1093/JNCI/91.23.2032